nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCB11—Paclitaxel—ovarian cancer	0.212	0.259	CbGbCtD
Fluorescein—ABCC1—Epirubicin—ovarian cancer	0.153	0.186	CbGbCtD
Fluorescein—ABCC1—Paclitaxel—ovarian cancer	0.151	0.184	CbGbCtD
Fluorescein—ABCB11—Doxorubicin—ovarian cancer	0.114	0.139	CbGbCtD
Fluorescein—ABCC1—Docetaxel—ovarian cancer	0.109	0.133	CbGbCtD
Fluorescein—ABCC1—Doxorubicin—ovarian cancer	0.0812	0.099	CbGbCtD
Fluorescein—Discomfort—Vinorelbine—ovarian cancer	0.000521	0.00289	CcSEcCtD
Fluorescein—Paraesthesia—Melphalan—ovarian cancer	0.000519	0.00288	CcSEcCtD
Fluorescein—Dyspnoea—Melphalan—ovarian cancer	0.000516	0.00286	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00051	0.00283	CcSEcCtD
Fluorescein—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000505	0.00281	CcSEcCtD
Fluorescein—Pain—Topotecan—ovarian cancer	0.000505	0.0028	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000499	0.00277	CcSEcCtD
Fluorescein—Bronchospasm—Docetaxel—ovarian cancer	0.000498	0.00277	CcSEcCtD
Fluorescein—Nervous system disorder—Vinorelbine—ovarian cancer	0.000495	0.00275	CcSEcCtD
Fluorescein—Pain—Melphalan—ovarian cancer	0.000495	0.00275	CcSEcCtD
Fluorescein—Angina pectoris—Docetaxel—ovarian cancer	0.000493	0.00274	CcSEcCtD
Fluorescein—Tachycardia—Vinorelbine—ovarian cancer	0.000493	0.00274	CcSEcCtD
Fluorescein—Neoplasm—Epirubicin—ovarian cancer	0.000492	0.00273	CcSEcCtD
Fluorescein—Skin disorder—Vinorelbine—ovarian cancer	0.000491	0.00273	CcSEcCtD
Fluorescein—Hypersensitivity—Chlorambucil—ovarian cancer	0.000489	0.00271	CcSEcCtD
Fluorescein—Bradycardia—Paclitaxel—ovarian cancer	0.000487	0.0027	CcSEcCtD
Fluorescein—Feeling abnormal—Topotecan—ovarian cancer	0.000487	0.0027	CcSEcCtD
Fluorescein—Pulmonary oedema—Epirubicin—ovarian cancer	0.000485	0.00269	CcSEcCtD
Fluorescein—Gastrointestinal pain—Topotecan—ovarian cancer	0.000483	0.00268	CcSEcCtD
Fluorescein—Asthenia—Chlorambucil—ovarian cancer	0.000476	0.00264	CcSEcCtD
Fluorescein—Hypoaesthesia—Paclitaxel—ovarian cancer	0.000476	0.00264	CcSEcCtD
Fluorescein—Hypotension—Vinorelbine—ovarian cancer	0.000472	0.00262	CcSEcCtD
Fluorescein—Pruritus—Chlorambucil—ovarian cancer	0.000469	0.00261	CcSEcCtD
Fluorescein—Urticaria—Topotecan—ovarian cancer	0.000469	0.00261	CcSEcCtD
Fluorescein—Abdominal pain—Topotecan—ovarian cancer	0.000467	0.00259	CcSEcCtD
Fluorescein—Urticaria—Melphalan—ovarian cancer	0.000459	0.00255	CcSEcCtD
Fluorescein—Thrombophlebitis—Epirubicin—ovarian cancer	0.000457	0.00254	CcSEcCtD
Fluorescein—Neoplasm—Doxorubicin—ovarian cancer	0.000456	0.00253	CcSEcCtD
Fluorescein—Paraesthesia—Vinorelbine—ovarian cancer	0.000454	0.00252	CcSEcCtD
Fluorescein—Dyspnoea—Vinorelbine—ovarian cancer	0.00045	0.0025	CcSEcCtD
Fluorescein—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000449	0.00249	CcSEcCtD
Fluorescein—Cardiac disorder—Paclitaxel—ovarian cancer	0.000444	0.00247	CcSEcCtD
Fluorescein—Eczema—Epirubicin—ovarian cancer	0.00044	0.00244	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000436	0.00242	CcSEcCtD
Fluorescein—Hypersensitivity—Topotecan—ovarian cancer	0.000435	0.00242	CcSEcCtD
Fluorescein—Angiopathy—Paclitaxel—ovarian cancer	0.000434	0.00241	CcSEcCtD
Fluorescein—Pain—Vinorelbine—ovarian cancer	0.000432	0.0024	CcSEcCtD
Fluorescein—Immune system disorder—Paclitaxel—ovarian cancer	0.000432	0.0024	CcSEcCtD
Fluorescein—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000431	0.00239	CcSEcCtD
Fluorescein—Chills—Paclitaxel—ovarian cancer	0.000429	0.00238	CcSEcCtD
Fluorescein—Hypersensitivity—Melphalan—ovarian cancer	0.000426	0.00237	CcSEcCtD
Fluorescein—Asthenia—Topotecan—ovarian cancer	0.000424	0.00235	CcSEcCtD
Fluorescein—Hot flush—Epirubicin—ovarian cancer	0.000423	0.00235	CcSEcCtD
Fluorescein—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000423	0.00235	CcSEcCtD
Fluorescein—Vomiting—Chlorambucil—ovarian cancer	0.000422	0.00234	CcSEcCtD
Fluorescein—Menopausal symptoms—Epirubicin—ovarian cancer	0.000419	0.00233	CcSEcCtD
Fluorescein—Pruritus—Topotecan—ovarian cancer	0.000418	0.00232	CcSEcCtD
Fluorescein—Erythema—Paclitaxel—ovarian cancer	0.000416	0.00231	CcSEcCtD
Fluorescein—Feeling abnormal—Vinorelbine—ovarian cancer	0.000416	0.00231	CcSEcCtD
Fluorescein—Asthenia—Melphalan—ovarian cancer	0.000415	0.0023	CcSEcCtD
Fluorescein—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000413	0.00229	CcSEcCtD
Fluorescein—Pruritus—Melphalan—ovarian cancer	0.000409	0.00227	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000408	0.00227	CcSEcCtD
Fluorescein—Dysgeusia—Paclitaxel—ovarian cancer	0.000408	0.00226	CcSEcCtD
Fluorescein—Eczema—Doxorubicin—ovarian cancer	0.000407	0.00226	CcSEcCtD
Fluorescein—Hypoaesthesia—Docetaxel—ovarian cancer	0.000403	0.00224	CcSEcCtD
Fluorescein—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000403	0.00224	CcSEcCtD
Fluorescein—Urticaria—Vinorelbine—ovarian cancer	0.000401	0.00223	CcSEcCtD
Fluorescein—Abdominal pain—Vinorelbine—ovarian cancer	0.000399	0.00222	CcSEcCtD
Fluorescein—Nausea—Chlorambucil—ovarian cancer	0.000394	0.00219	CcSEcCtD
Fluorescein—Hot flush—Doxorubicin—ovarian cancer	0.000391	0.00217	CcSEcCtD
Fluorescein—Dizziness—Topotecan—ovarian cancer	0.000391	0.00217	CcSEcCtD
Fluorescein—Tremor—Paclitaxel—ovarian cancer	0.00039	0.00217	CcSEcCtD
Fluorescein—Menopausal symptoms—Doxorubicin—ovarian cancer	0.000388	0.00215	CcSEcCtD
Fluorescein—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000386	0.00215	CcSEcCtD
Fluorescein—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000378	0.0021	CcSEcCtD
Fluorescein—Cardiac disorder—Docetaxel—ovarian cancer	0.000376	0.00209	CcSEcCtD
Fluorescein—Cardiac arrest—Epirubicin—ovarian cancer	0.000376	0.00209	CcSEcCtD
Fluorescein—Vomiting—Topotecan—ovarian cancer	0.000376	0.00209	CcSEcCtD
Fluorescein—Malaise—Paclitaxel—ovarian cancer	0.000376	0.00209	CcSEcCtD
Fluorescein—Syncope—Paclitaxel—ovarian cancer	0.000373	0.00207	CcSEcCtD
Fluorescein—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.000373	0.00207	CcSEcCtD
Fluorescein—Rash—Topotecan—ovarian cancer	0.000372	0.00207	CcSEcCtD
Fluorescein—Hypersensitivity—Vinorelbine—ovarian cancer	0.000372	0.00207	CcSEcCtD
Fluorescein—Dermatitis—Topotecan—ovarian cancer	0.000372	0.00207	CcSEcCtD
Fluorescein—Headache—Topotecan—ovarian cancer	0.00037	0.00205	CcSEcCtD
Fluorescein—Angiopathy—Docetaxel—ovarian cancer	0.000368	0.00204	CcSEcCtD
Fluorescein—Vomiting—Melphalan—ovarian cancer	0.000368	0.00204	CcSEcCtD
Fluorescein—Immune system disorder—Docetaxel—ovarian cancer	0.000366	0.00203	CcSEcCtD
Fluorescein—Loss of consciousness—Paclitaxel—ovarian cancer	0.000366	0.00203	CcSEcCtD
Fluorescein—Mediastinal disorder—Docetaxel—ovarian cancer	0.000365	0.00203	CcSEcCtD
Fluorescein—Rash—Melphalan—ovarian cancer	0.000365	0.00202	CcSEcCtD
Fluorescein—Dermatitis—Melphalan—ovarian cancer	0.000364	0.00202	CcSEcCtD
Fluorescein—Chills—Docetaxel—ovarian cancer	0.000364	0.00202	CcSEcCtD
Fluorescein—Cough—Paclitaxel—ovarian cancer	0.000363	0.00202	CcSEcCtD
Fluorescein—Asthenia—Vinorelbine—ovarian cancer	0.000363	0.00201	CcSEcCtD
Fluorescein—Convulsion—Paclitaxel—ovarian cancer	0.000361	0.002	CcSEcCtD
Fluorescein—Hypertension—Paclitaxel—ovarian cancer	0.00036	0.002	CcSEcCtD
Fluorescein—Pruritus—Vinorelbine—ovarian cancer	0.000357	0.00199	CcSEcCtD
Fluorescein—Chest pain—Paclitaxel—ovarian cancer	0.000355	0.00197	CcSEcCtD
Fluorescein—Erythema—Docetaxel—ovarian cancer	0.000353	0.00196	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000352	0.00196	CcSEcCtD
Fluorescein—Nausea—Topotecan—ovarian cancer	0.000351	0.00195	CcSEcCtD
Fluorescein—Discomfort—Paclitaxel—ovarian cancer	0.00035	0.00195	CcSEcCtD
Fluorescein—Cardiac arrest—Doxorubicin—ovarian cancer	0.000348	0.00193	CcSEcCtD
Fluorescein—Dysgeusia—Docetaxel—ovarian cancer	0.000346	0.00192	CcSEcCtD
Fluorescein—Nausea—Melphalan—ovarian cancer	0.000344	0.00191	CcSEcCtD
Fluorescein—Asthma—Epirubicin—ovarian cancer	0.000342	0.0019	CcSEcCtD
Fluorescein—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00034	0.00189	CcSEcCtD
Fluorescein—Oedema—Paclitaxel—ovarian cancer	0.00034	0.00189	CcSEcCtD
Fluorescein—Shock—Paclitaxel—ovarian cancer	0.000334	0.00186	CcSEcCtD
Fluorescein—Dizziness—Vinorelbine—ovarian cancer	0.000334	0.00186	CcSEcCtD
Fluorescein—Nervous system disorder—Paclitaxel—ovarian cancer	0.000333	0.00185	CcSEcCtD
Fluorescein—Angina pectoris—Epirubicin—ovarian cancer	0.000333	0.00185	CcSEcCtD
Fluorescein—Tachycardia—Paclitaxel—ovarian cancer	0.000332	0.00184	CcSEcCtD
Fluorescein—Skin disorder—Paclitaxel—ovarian cancer	0.00033	0.00183	CcSEcCtD
Fluorescein—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000329	0.00182	CcSEcCtD
Fluorescein—Vomiting—Vinorelbine—ovarian cancer	0.000321	0.00178	CcSEcCtD
Fluorescein—Rash—Vinorelbine—ovarian cancer	0.000319	0.00177	CcSEcCtD
Fluorescein—Dermatitis—Vinorelbine—ovarian cancer	0.000318	0.00177	CcSEcCtD
Fluorescein—Hypotension—Paclitaxel—ovarian cancer	0.000318	0.00176	CcSEcCtD
Fluorescein—Headache—Vinorelbine—ovarian cancer	0.000317	0.00176	CcSEcCtD
Fluorescein—Syncope—Docetaxel—ovarian cancer	0.000317	0.00176	CcSEcCtD
Fluorescein—Asthma—Doxorubicin—ovarian cancer	0.000316	0.00176	CcSEcCtD
Fluorescein—Loss of consciousness—Docetaxel—ovarian cancer	0.00031	0.00172	CcSEcCtD
Fluorescein—Cough—Docetaxel—ovarian cancer	0.000308	0.00171	CcSEcCtD
Fluorescein—Angina pectoris—Doxorubicin—ovarian cancer	0.000308	0.00171	CcSEcCtD
Fluorescein—Convulsion—Docetaxel—ovarian cancer	0.000306	0.0017	CcSEcCtD
Fluorescein—Paraesthesia—Paclitaxel—ovarian cancer	0.000305	0.00169	CcSEcCtD
Fluorescein—Hypertension—Docetaxel—ovarian cancer	0.000305	0.00169	CcSEcCtD
Fluorescein—Dyspnoea—Paclitaxel—ovarian cancer	0.000303	0.00168	CcSEcCtD
Fluorescein—Chest pain—Docetaxel—ovarian cancer	0.0003	0.00167	CcSEcCtD
Fluorescein—Nausea—Vinorelbine—ovarian cancer	0.0003	0.00167	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000298	0.00166	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000293	0.00163	CcSEcCtD
Fluorescein—Pain—Paclitaxel—ovarian cancer	0.000291	0.00161	CcSEcCtD
Fluorescein—Anaphylactic shock—Docetaxel—ovarian cancer	0.000288	0.0016	CcSEcCtD
Fluorescein—Oedema—Docetaxel—ovarian cancer	0.000288	0.0016	CcSEcCtD
Fluorescein—Shock—Docetaxel—ovarian cancer	0.000283	0.00157	CcSEcCtD
Fluorescein—Nervous system disorder—Docetaxel—ovarian cancer	0.000282	0.00157	CcSEcCtD
Fluorescein—Tachycardia—Docetaxel—ovarian cancer	0.000281	0.00156	CcSEcCtD
Fluorescein—Feeling abnormal—Paclitaxel—ovarian cancer	0.00028	0.00156	CcSEcCtD
Fluorescein—Skin disorder—Docetaxel—ovarian cancer	0.00028	0.00155	CcSEcCtD
Fluorescein—Bradycardia—Epirubicin—ovarian cancer	0.000278	0.00155	CcSEcCtD
Fluorescein—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000278	0.00154	CcSEcCtD
Fluorescein—Hypoaesthesia—Epirubicin—ovarian cancer	0.000272	0.00151	CcSEcCtD
Fluorescein—Urticaria—Paclitaxel—ovarian cancer	0.00027	0.0015	CcSEcCtD
Fluorescein—Hypotension—Docetaxel—ovarian cancer	0.000269	0.00149	CcSEcCtD
Fluorescein—Abdominal pain—Paclitaxel—ovarian cancer	0.000269	0.00149	CcSEcCtD
Fluorescein—Paraesthesia—Docetaxel—ovarian cancer	0.000259	0.00144	CcSEcCtD
Fluorescein—Bradycardia—Doxorubicin—ovarian cancer	0.000258	0.00143	CcSEcCtD
Fluorescein—Dyspnoea—Docetaxel—ovarian cancer	0.000257	0.00143	CcSEcCtD
Fluorescein—Cardiac disorder—Epirubicin—ovarian cancer	0.000254	0.00141	CcSEcCtD
Fluorescein—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000252	0.0014	CcSEcCtD
Fluorescein—Hypersensitivity—Paclitaxel—ovarian cancer	0.00025	0.00139	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000249	0.00138	CcSEcCtD
Fluorescein—Angiopathy—Epirubicin—ovarian cancer	0.000248	0.00138	CcSEcCtD
Fluorescein—Immune system disorder—Epirubicin—ovarian cancer	0.000247	0.00137	CcSEcCtD
Fluorescein—Mediastinal disorder—Epirubicin—ovarian cancer	0.000246	0.00137	CcSEcCtD
Fluorescein—Pain—Docetaxel—ovarian cancer	0.000246	0.00137	CcSEcCtD
Fluorescein—Chills—Epirubicin—ovarian cancer	0.000245	0.00136	CcSEcCtD
Fluorescein—Asthenia—Paclitaxel—ovarian cancer	0.000244	0.00135	CcSEcCtD
Fluorescein—Pruritus—Paclitaxel—ovarian cancer	0.00024	0.00134	CcSEcCtD
Fluorescein—Erythema—Epirubicin—ovarian cancer	0.000238	0.00132	CcSEcCtD
Fluorescein—Feeling abnormal—Docetaxel—ovarian cancer	0.000237	0.00132	CcSEcCtD
Fluorescein—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000236	0.00131	CcSEcCtD
Fluorescein—Cardiac disorder—Doxorubicin—ovarian cancer	0.000235	0.0013	CcSEcCtD
Fluorescein—Dysgeusia—Epirubicin—ovarian cancer	0.000233	0.00129	CcSEcCtD
Fluorescein—Angiopathy—Doxorubicin—ovarian cancer	0.00023	0.00127	CcSEcCtD
Fluorescein—Immune system disorder—Doxorubicin—ovarian cancer	0.000229	0.00127	CcSEcCtD
Fluorescein—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000228	0.00127	CcSEcCtD
Fluorescein—Abdominal pain—Docetaxel—ovarian cancer	0.000228	0.00126	CcSEcCtD
Fluorescein—Chills—Doxorubicin—ovarian cancer	0.000227	0.00126	CcSEcCtD
Fluorescein—Dizziness—Paclitaxel—ovarian cancer	0.000225	0.00125	CcSEcCtD
Fluorescein—Ill-defined disorder—Epirubicin—ovarian cancer	0.000221	0.00123	CcSEcCtD
Fluorescein—Erythema—Doxorubicin—ovarian cancer	0.00022	0.00122	CcSEcCtD
Fluorescein—Vomiting—Paclitaxel—ovarian cancer	0.000216	0.0012	CcSEcCtD
Fluorescein—Dysgeusia—Doxorubicin—ovarian cancer	0.000216	0.0012	CcSEcCtD
Fluorescein—Malaise—Epirubicin—ovarian cancer	0.000215	0.00119	CcSEcCtD
Fluorescein—Rash—Paclitaxel—ovarian cancer	0.000214	0.00119	CcSEcCtD
Fluorescein—Dermatitis—Paclitaxel—ovarian cancer	0.000214	0.00119	CcSEcCtD
Fluorescein—Syncope—Epirubicin—ovarian cancer	0.000213	0.00119	CcSEcCtD
Fluorescein—Headache—Paclitaxel—ovarian cancer	0.000213	0.00118	CcSEcCtD
Fluorescein—Hypersensitivity—Docetaxel—ovarian cancer	0.000212	0.00118	CcSEcCtD
Fluorescein—Loss of consciousness—Epirubicin—ovarian cancer	0.000209	0.00116	CcSEcCtD
Fluorescein—Cough—Epirubicin—ovarian cancer	0.000208	0.00115	CcSEcCtD
Fluorescein—Asthenia—Docetaxel—ovarian cancer	0.000207	0.00115	CcSEcCtD
Fluorescein—Convulsion—Epirubicin—ovarian cancer	0.000206	0.00115	CcSEcCtD
Fluorescein—Hypertension—Epirubicin—ovarian cancer	0.000206	0.00114	CcSEcCtD
Fluorescein—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000204	0.00113	CcSEcCtD
Fluorescein—Pruritus—Docetaxel—ovarian cancer	0.000204	0.00113	CcSEcCtD
Fluorescein—Chest pain—Epirubicin—ovarian cancer	0.000203	0.00113	CcSEcCtD
Fluorescein—Nausea—Paclitaxel—ovarian cancer	0.000202	0.00112	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000201	0.00112	CcSEcCtD
Fluorescein—Discomfort—Epirubicin—ovarian cancer	0.0002	0.00111	CcSEcCtD
Fluorescein—Malaise—Doxorubicin—ovarian cancer	0.000199	0.0011	CcSEcCtD
Fluorescein—Syncope—Doxorubicin—ovarian cancer	0.000198	0.0011	CcSEcCtD
Fluorescein—Anaphylactic shock—Epirubicin—ovarian cancer	0.000194	0.00108	CcSEcCtD
Fluorescein—Oedema—Epirubicin—ovarian cancer	0.000194	0.00108	CcSEcCtD
Fluorescein—Loss of consciousness—Doxorubicin—ovarian cancer	0.000194	0.00108	CcSEcCtD
Fluorescein—Cough—Doxorubicin—ovarian cancer	0.000192	0.00107	CcSEcCtD
Fluorescein—Shock—Epirubicin—ovarian cancer	0.000191	0.00106	CcSEcCtD
Fluorescein—Convulsion—Doxorubicin—ovarian cancer	0.000191	0.00106	CcSEcCtD
Fluorescein—Nervous system disorder—Epirubicin—ovarian cancer	0.000191	0.00106	CcSEcCtD
Fluorescein—Dizziness—Docetaxel—ovarian cancer	0.00019	0.00106	CcSEcCtD
Fluorescein—Hypertension—Doxorubicin—ovarian cancer	0.00019	0.00106	CcSEcCtD
Fluorescein—Tachycardia—Epirubicin—ovarian cancer	0.00019	0.00105	CcSEcCtD
Fluorescein—Skin disorder—Epirubicin—ovarian cancer	0.000189	0.00105	CcSEcCtD
Fluorescein—Hyperhidrosis—Epirubicin—ovarian cancer	0.000188	0.00104	CcSEcCtD
Fluorescein—Chest pain—Doxorubicin—ovarian cancer	0.000188	0.00104	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000186	0.00103	CcSEcCtD
Fluorescein—Discomfort—Doxorubicin—ovarian cancer	0.000185	0.00103	CcSEcCtD
Fluorescein—Vomiting—Docetaxel—ovarian cancer	0.000183	0.00102	CcSEcCtD
Fluorescein—Rash—Docetaxel—ovarian cancer	0.000182	0.00101	CcSEcCtD
Fluorescein—Hypotension—Epirubicin—ovarian cancer	0.000182	0.00101	CcSEcCtD
Fluorescein—Dermatitis—Docetaxel—ovarian cancer	0.000181	0.00101	CcSEcCtD
Fluorescein—Headache—Docetaxel—ovarian cancer	0.00018	0.001	CcSEcCtD
Fluorescein—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00018	0.000998	CcSEcCtD
Fluorescein—Oedema—Doxorubicin—ovarian cancer	0.00018	0.000998	CcSEcCtD
Fluorescein—Shock—Doxorubicin—ovarian cancer	0.000177	0.000982	CcSEcCtD
Fluorescein—Nervous system disorder—Doxorubicin—ovarian cancer	0.000176	0.000979	CcSEcCtD
Fluorescein—Tachycardia—Doxorubicin—ovarian cancer	0.000175	0.000974	CcSEcCtD
Fluorescein—Skin disorder—Doxorubicin—ovarian cancer	0.000175	0.00097	CcSEcCtD
Fluorescein—Paraesthesia—Epirubicin—ovarian cancer	0.000174	0.000969	CcSEcCtD
Fluorescein—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000174	0.000965	CcSEcCtD
Fluorescein—Dyspnoea—Epirubicin—ovarian cancer	0.000173	0.000962	CcSEcCtD
Fluorescein—Nausea—Docetaxel—ovarian cancer	0.000171	0.00095	CcSEcCtD
Fluorescein—Hypotension—Doxorubicin—ovarian cancer	0.000168	0.000933	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000168	0.000931	CcSEcCtD
Fluorescein—Pain—Epirubicin—ovarian cancer	0.000166	0.000923	CcSEcCtD
Fluorescein—Paraesthesia—Doxorubicin—ovarian cancer	0.000161	0.000896	CcSEcCtD
Fluorescein—Dyspnoea—Doxorubicin—ovarian cancer	0.00016	0.00089	CcSEcCtD
Fluorescein—Feeling abnormal—Epirubicin—ovarian cancer	0.00016	0.000889	CcSEcCtD
Fluorescein—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000159	0.000882	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000155	0.000862	CcSEcCtD
Fluorescein—Urticaria—Epirubicin—ovarian cancer	0.000154	0.000857	CcSEcCtD
Fluorescein—Pain—Doxorubicin—ovarian cancer	0.000154	0.000854	CcSEcCtD
Fluorescein—Abdominal pain—Epirubicin—ovarian cancer	0.000154	0.000853	CcSEcCtD
Fluorescein—Feeling abnormal—Doxorubicin—ovarian cancer	0.000148	0.000823	CcSEcCtD
Fluorescein—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000147	0.000816	CcSEcCtD
Fluorescein—Hypersensitivity—Epirubicin—ovarian cancer	0.000143	0.000795	CcSEcCtD
Fluorescein—Urticaria—Doxorubicin—ovarian cancer	0.000143	0.000793	CcSEcCtD
Fluorescein—Abdominal pain—Doxorubicin—ovarian cancer	0.000142	0.000789	CcSEcCtD
Fluorescein—Asthenia—Epirubicin—ovarian cancer	0.000139	0.000774	CcSEcCtD
Fluorescein—Pruritus—Epirubicin—ovarian cancer	0.000137	0.000763	CcSEcCtD
Fluorescein—Hypersensitivity—Doxorubicin—ovarian cancer	0.000132	0.000736	CcSEcCtD
Fluorescein—Asthenia—Doxorubicin—ovarian cancer	0.000129	0.000716	CcSEcCtD
Fluorescein—Dizziness—Epirubicin—ovarian cancer	0.000128	0.000713	CcSEcCtD
Fluorescein—Pruritus—Doxorubicin—ovarian cancer	0.000127	0.000706	CcSEcCtD
Fluorescein—Vomiting—Epirubicin—ovarian cancer	0.000124	0.000686	CcSEcCtD
Fluorescein—Rash—Epirubicin—ovarian cancer	0.000123	0.00068	CcSEcCtD
Fluorescein—Dermatitis—Epirubicin—ovarian cancer	0.000122	0.00068	CcSEcCtD
Fluorescein—Headache—Epirubicin—ovarian cancer	0.000122	0.000676	CcSEcCtD
Fluorescein—Dizziness—Doxorubicin—ovarian cancer	0.000119	0.00066	CcSEcCtD
Fluorescein—Nausea—Epirubicin—ovarian cancer	0.000115	0.000641	CcSEcCtD
Fluorescein—Vomiting—Doxorubicin—ovarian cancer	0.000114	0.000635	CcSEcCtD
Fluorescein—Rash—Doxorubicin—ovarian cancer	0.000113	0.000629	CcSEcCtD
Fluorescein—Dermatitis—Doxorubicin—ovarian cancer	0.000113	0.000629	CcSEcCtD
Fluorescein—Headache—Doxorubicin—ovarian cancer	0.000113	0.000625	CcSEcCtD
Fluorescein—Nausea—Doxorubicin—ovarian cancer	0.000107	0.000593	CcSEcCtD
